Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders

Anatomical Record

Volumn 294, Issue 10, 2011, Pages 1726-1735

  Rodriguez Porcel, Federico ^a   Green, Donald ^b   Khatri, Nidhi ^b   Harris, Sharonda Swilley ^b   May, Warren L ^b   Lin, Rick C S ^a,b   Paul, Ian A ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Autism; Development; Sensory systems; Serotonin

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; CHILD BEHAVIOR; CONTROLLED STUDY; DRUG EXPOSURE; ESTRUS; FEMALE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SEXUAL BEHAVIOR; SOCIAL INTERACTION; WEANING;

ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; HUMANS; LOCOMOTION; MALE; PREGNANCY; RATS; RATS, LONG-EVANS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR;

RATTUS;

EID: 80052989971     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21402     Document Type: Article

References (37)

1. Albert DJ, Walsh ML. 1982. The inhibitory modulation of agonistic behavior in the rat brain: a review. Neurosci Biobehav Rev 6: 125-143.
2. Baranek GT, Berkson G. 1994. Tactile defensiveness in children with developmental disabilities: responsiveness and habituation. J Autism Dev Disord 24: 457-471.
3. Beyer C, Contreras JL, Morali G, Larsson K. 1981. Effects of castration and sex steroid treatment on the motor copulatory pattern of the rat. Physiol Behav 27: 727-730.
4. Blanchard RJ, Wall PM, Blanchard DC. 2003. Problems in the study of rodent aggression. Horm Behav 44: 161-170.
5. Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M. 2004. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial. Psychosom Med 66: 707-713.
6. De Boer S, Mirmiran M, Van Haaren F, Louwerse A, van de Poll NE. 1989. Neurobehavioral teratogenic effects of clomipramine and alpha-methyldopa. Neurotoxicol Teratol 11: 77-84.
7. Egaas B, Courchesne E, Saitoh O. 1995. Reduced size of corpus callosum in autism. Arch Neurol 52: 794-801.
8. Fink G, Sumner B, Rosie R, Wilson H, McQueen J. 1999. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105: 53-68.
9. Genn RF, Tucci S, Edwards JE, File SE. 2003. Dietary restriction and nicotine can reduce anxiety in female rats. Neuropsychopharmacology 28: 1257-1263.
10. Gomot M, Belmonte MK, Bullmore ET, Bernard FA, Baron-Cohen S. 2008. Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain 131: 2479-2488.
11. Hansson SR, Mezey E, Hoffman BJ. 1998. Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons. Neuroscience 83: 1185-1201.
12. Harkin A, Nowak G, Paul IA. 2000. Corrigendum to: "Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors". Eur J Pharmacol 397: 399.
13. Haroutunian V, Kanof PD, Tsuboyama GK, Campbell GA, Davis KL. 1986. Animal models of Alzheimer's disease: behavior, pharmacology, transplants. Can J Neurol Sci 13: 385-393.
14. Hull EM, Dominguez JM. 2007. Sexual behavior in male rodents. Horm Behav 52: 45-55.
15. Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, Whitaker-Azmitia PM. 2002. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 75: 403-410.
16. Khalfa S, Bruneau N, Roge B, Georgieff N, Veuillet E, Adrien JL, Barthelemy C, Collet L. 2001. Peripheral auditory asymmetry in infantile autism. Eur J Neurosci 13: 628-632.
17. Kim SJ, Lee SY, Lee C, Kim I, An HJ, Kim JY, Baek KH, Kim EJ, Kim JM, Lee JB, Lee JW, Jung WW, Chun T, Oh YK. 2006. Differential expression profiling of genes in a complete hydatidiform mole using cDNA microarray analysis. Gynecol Oncol 103: 654-660.
18. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, Seif I, Gaspar P. 1996. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17: 823-835.
19. Lebrand C, Cases O, Wehrle R, Blakely RD, Edwards RH, Gaspar P. 1998. Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol 401: 506-524.
20. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC, Paul IA. 2006. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31: 47-57.
21. Maki PM, Dumas J. 2009. Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med 27: 250-259.
22. McLean JH, Shipley MT. 1987a. Serotonergic afferents to the rat olfactory bulb: I. Origins and laminar specificity of serotonergic inputs in the adult rat. J Neurosci 7: 3016-3028.
23. McLean JH, Shipley MT. 1987b. Serotonergic afferents to the rat olfactory bulb: II. Changes in fiber distribution during development. J Neurosci 7: 3029-3039.
24. McNamara IM, Borella AW, Bialowas LA, Whitaker-Azmitia PM. 2008. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res 1189: 203-214.
25. Mirmiran M, van de Poll NE, Corner MA, van Oyen HG, Bour HL. 1981. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204: 129-146.
26. Nicholas JS, Carpenter LA, King LB, Jenner W, Charles JM. 2009. Autism spectrum disorders in preschool-aged children: prevalence and comparison to a school-aged population. Ann Epidemiol 19: 808-814.
27. Pittenger C, Duman RS. 2008. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33: 88-109.
28. Severino SK, Yonkers KA. 1993. A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics 34: 299-306.
29. Sikich L. 2001. Psychopharmacologic treatment studies in autism. In: Schopler E, Yirmiya N, Schulman C, Marcus L, editors. The research basis for autism intervention. New York: Kluwer Academic/Plenum Publishers. p 199-218.
30. Task Force on DSM-IV. 1994. Diagnostic and statistical manual of mental disorders, Fourth edition (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association.
31. The Task Force on DSM-IV. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
32. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. 2006. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
33. Vogel GW, Feng P, Kinney GG. 2000. Ontogeny of REM sleep in rats: possible implications for endogenous depression. Physiol Behav 68: 453-461.
34. Weaver KJ, Paul IA, Lin RC, Simpson KL. 2010. Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat Rec (Hoboken) 293: 1920-1932.
35. Whitaker-Azmitia PM. 2005. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23: 75-83.
36. Winslow JT, Insel TR. 1990. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3, 4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 254: 212-220.
37. Zhang L, Ma W, Barker JL, Rubinow DR. 1999. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 94: 251-259.